FibroBiologics Inc. Intellectual Property Contracts & Agreements

5 Contracts & Agreements

Browse by Subcategory

License Agreements (5 contracts)

Recent Contracts

Amendment No. 4, effective January 1, 2023, to the License Agreement between K2 Biolabs, LLC and FibroBiologics, Inc (Filed With SEC on November 28, 2023)
Amendment No. 3, effective October 1, 2022, to the License Agreement between K2 Biolabs, LLC and FibroBiologics, Inc (Filed With SEC on November 28, 2023)
Amendment No. 2, effective August 1, 2022, to the License Agreement between K2 Biolabs, LLC and FibroBiologics, Inc (Filed With SEC on November 28, 2023)
Amendment No. 1, effective July 1, 2022, to the License Agreement between K2 Biolabs, LLC and FibroBiologics, Inc (Filed With SEC on November 28, 2023)
License Agreement, dated November 30, 2021, between K2 Biolabs, LLC and FibroBiologics, LLC (Filed With SEC on November 28, 2023)